Description
Used in the treatment of:
- Metastatic colorectal cancer
- Renal cell carcinoma
- Glioblastoma
- NSCLC and ovarian cancers
Bevacizumab is a VEGF-inhibiting monoclonal antibody that prevents angiogenesis and restricts tumor blood supply.
Support Email: info@biomedspecialitypharma.com
PRODUCT SPECIFICATION
Strength / Dose: 400 mg
Dosage Form: Concentrate for intravenous infusion
Packing Type: Glass vial with rubber stopper, packed in carton
Treatment:
Used in the treatment of:
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Bevacizumab
Brand: Bevakalp 400
Used in the treatment of:
PRODUCT SPECIFICATION
Strength / Dose: 500 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets packed in blister or bottle, packed in carton
Treatment:
Used in the treatment of:
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Abiraterone Acetate
Brand: Abiratas 500
Our global distribution network and regulatory expertise enable us to deliver world-class pharmaceutical products that meet local market needs.
Address: DGS Sheetal Regalia, 209, Nensey Colony, Borivali East, Mumbai, Maharashtra 400066
Support mail: info@biomedspecialitypharma.com
Opening Hours: Monday – Saturday: 10.00am – 08.00pm